TG Therapeutics | TGTX - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
AbbVie USD 435.86B 8.73B 2026-08
Alaunos Therapeutics USD 7M 2M 2026-03
Amgen USD 209.65B 14.21B 2026-08
Ardelyx USD 1.48B 63M 2026-03
Arrowhead Research USD 10.84B 664M 2026-08
Bayer EUR 48.39B 834.21M 2026-08
Biogen USD 31.9B 5B 2026-06
Corcept Therapeutics USD 9.33B 5.02B 2026-06
Curis USD 10M 2M 2026-08
Gilead Sciences USD 168.68B 11.82B 2026-08
J&J USD 611.36B 32.21B 2026-06
Karyopharm Therapeutics USD 221M 95M 2026-08
Novartis USD 240.59B 67.17B 2026-06
Novavax USD 1.09B 316M 2025-12
Regeneron Pharmaceuticals USD 65.37B 16.31B 2026-06
Roche Holding CHF 270B 3.66B 2026-06
TG Therapeutics USD 7.63B 778M 2026-08
Verastem USD 147M 319M 2026-08
Vertex Pharmaceuticals USD 137.33B 11.26B 2026-08